Previous 10 | Next 10 |
Channelchek news releases related Channelchek news releases and Channelchek press releases from 05/16/22 12:00:00 on US and Canada Markets.
First quarter results reflect higher prices. Revenues in the 2022 first quarter were $14.0m versus $6.9m and our $13.4m projection. Higher revenues reflect a 15% increase in production and a 48% increase in prices ($10.03/mcf). As a result of higher prices, operating netbacks rose to $53.94/bo...
1Q22 Results. One Stop Systems reported record first quarter revenue of $17.1 million, up 28% y-o-y and above management's $16.8 million guide. We had forecast $16.8 million. GAAP net income of $579,200, or $0.03 per share, versus net income of $41,300, or breakeven per share, last year. Adjus...
1Q22 Results. One Stop Systems reported record first quarter revenue of $17.1 million, up 28% y-o-y and above management's $16.8 million guide. We had forecast $16.8 million. GAAP net income of $579,200, or $0.03 per share, versus net income of $41,300, or breakeven per share, last year. Adjus...
Q1 meets expectations. The company reported Q1 revenue of $4.26 million, in line with our estimate of $4.29 million. Adj. EBITDA of $0.68 million was roughly in line with our estimate of $0.63 million. Management credited an increase in clients, as well as higher usage per client, as the catal...
A New Credit Facility....Friday, CoreCivic reported it had entered into a New Credit Agreement effectively replacing the Company’s existing senior secured credit facilities. As of March 31st, CoreCivic had $167.5 million due April 2023 under its Term Loan A and $124 million due December...
First quarter earnings exceed expectations. Sierra Metals reported first quarter adjusted net income of $5.9 million, or $0.04 per share, compared with $4.7 million, or $0.03 per share, during the prior year period and our estimate of $5.5 million, or $0.03 per share. Adjusted EBITDA amounted ...
China Approval. Avivagen's oxidized carotenoid-based feed additive, OxC-beta, has received approval for use in China. This is a significant accomplishment for Avivagen and should have a positive impact on operating results going forward. China marks the second key market, along with Vietnam, i...
Q1 beats expectations. The company reported Q1 revenue of $49.1 million, a 12.1% increase over the prior year quarter and a solid 7.1% above our estimate of $45.8 million. Adj. EBITDA of $4.8 million, which increased 114% above the prior year quarter, beat our estimate of $2.3 million by 108%....
Lineage Reported 1Q22. Lineage Cell Therapies reported a loss of $7.1 million or $(0.04) per share. Revenues included recognition of a portion of the payment from the Roche/Genentech collaboration, with revenue to be recognized each quarter as obligations under the agreement are completed. Tot...
1Q22. Revenue of $1.296 billion was up 7.5% year-over-year (9% in constant currency). Consensus was $1.26 billion and we were also at $1.26 billion. Kelly reported operating earnings of $23.4 million, compared to $10.6 million a year ago. We were at $11.0 million. GAAP loss per share was $1.23...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
4.03%Change Percent:
NuZee Inc. Company Name:
NUZE Stock Symbol:
OTCMKTS Market:
mynuzee.com Website: